Nexus Epigenomics
BUILDING
A HUB FOR DECODING THE EPIGENOME
Problem
Our genes make us who we are, but they only make up 2% of our DNA. The remaining 98% (epigenome) regulates how, when, and where those genes get activated, and disrupted in disease. Our ability to understand (and eventually treat) disease is dependent on the availability of tools and technologies that can work together to give a holistic perspective of the epigenome.
Solution
At NEXUS, we are building a platform of technologies to profile the different layers of the epigenome in a versatile, easy-to-use, plug-and-play fashion. Our different products will enable users to efficiently target specific segments of gene regulation.
Our flagship product targets the deepest layer of the epigenome - DNA methylation. It uses our proprietary MeTLAND technology to capture methylation patterns across the genome in a way that is cheaper, more data-rich and easier to implement compared to existing alternatives.
Meet the Team
Co-Founder and CEO
-
Mukund holds a PhD in Molecular Neuroscience from the Karolinska Institute and is the CEO of NEXUS Epigenomics. With a strong foundation in epigenomics and chromatin biology, he has a proven track record in developing innovative genome-profiling technologies. Mukund’s expertise spans cutting-edge methods in single-cell genomics, which has enabled deeper insights into gene regulation and its impact on disease. At Nexus, he leads the strategic direction and will drive technology development.
Co-Founder and COO
-
Jana holds a PhD in Biomolecular Chemistry from Masaryk University and is the COO of NEXUS Epigenomics. With extensive biotech industry experience, she specialises in product development, quality control, kit production, and customer service management. Jana was instrumental in scaling operations at CARTANA AB, later driving technology development and early access programs as Project Manager at 10x Genomics following CARTANA’s acquisition.
Partners / Collaborators /
Partners / Collaborators /
Gonçalo Castelo-Branco, PhD (Scientific Advisor)
Gonçalo is a Distinguished Professor of Glial Cell Biology at the Karolinska Institute and a leading authority in single-cell and spatial epigenomics. With over 14,000 citations, publications in top-tier journals such as Science, Nature, and Cell, and the distinction of receiving multiple European Research Council grants, Gonçalo brings deep value as Scientific Advisor, guiding the development and application of our innovative technologies.
Marek Bartosovic, PhD (Scientific Advisor)
Marek holds a PhD in Biomolecular Chemistry from Masaryk University and is a group leader at Stockholm University, and Chair of the Board of Directors at NEXUS Epigenomics. In addition to being a co-inventor of MeTLAND, Marek has also developed cutting-edge single-cell, spatial, and multimodal technologies. As Scientific Advisor, he contributes to strategic discussions and fosters collaborations through his extensive network of KOLs.
